BRISTOL-MYERS SQUIBB COMPANY (OTCMKTS:BMYMP) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(d)On March 1, 2018, the Board of Directors of Bristol-Myers Squibb Company (the “Company”) elected Jose Baselga, M.D., Ph.D., 58, to serve as a member of the Board of Directors, effective March 1, 2018. The size of the Board of Directors was increased to twelve, effective March 1, 2018, in connection with Dr. Baselga’s election.